COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 80; no. 6; p. e95
Main Authors Kasap Cuceoglu, Muserref, Batu, Ezgi Deniz, Bilginer, Yelda, Özen, Seza
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd and European League Against Rheumatism 01.06.2021
BMJ Publishing Group LTD
Subjects
Adults
antirheumatic agents
Arthritis
CD20 antigen
Children
Coronaviruses
Correspondence
COVID-19
Cryopyrin
Disease control
Drugs
Familial Mediterranean fever
Hospitalization
Infections
Interleukin 1
Interleukin 6
Janus kinase
Mevalonate kinase
Mevalonic acid
Osteitis
Pandemics
Patients
Pediatrics
Polymerase chain reaction
Respiratory tract diseases
Rheumatic diseases
Rheumatology
Risk factors
RNA-directed DNA polymerase
Scleroderma
Severe acute respiratory syndrome coronavirus 2
Systemic sclerosis
Systemic vasculitis
Tumor necrosis factor
Tumor necrosis factor-TNF
Tumors
tumour necrosis factor inhibitors
Ankara Turkey
Turkey
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2020-218341